AI Verdict
HAE has stronger fundamentals based on our AI analysis.
HAS vs HAE Fundamental Comparison
| Metric | HAS | HAE |
|---|---|---|
| Revenue | $5.4B | $987.7M |
| Net Income | $-322.4M | $117.5M |
| Net Margin | -6.0% | 11.9% |
| ROE | -57.0% | 12.9% |
| ROA | -5.8% | 4.7% |
| Current Ratio | 1.38x | 1.75x |
| Debt/Equity | 4.89x | 1.34x |
| EPS | $-2.30 | $2.46 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HAS vs HAE: Frequently Asked Questions
Is HAS or HAE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HAE has stronger fundamentals. HAS is rated STRONG SELL (87% confidence) while HAE is rated BUY (72% confidence). This is not investment advice.
How does HAS compare to HAE fundamentally?
HASBRO, INC. has ROE of -57.0% vs HAEMONETICS CORP's 12.9%. Net margins are -6.0% vs 11.9% respectively.
Which stock pays higher dividends, HAS or HAE?
HAS has a dividend yield of N/A or no dividend while HAE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HAS or HAE for long term?
For long-term investing, consider that HAS has STRONG SELL rating with 87% confidence, while HAE has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HAS vs HAE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HAS vs HAE, the AI consensus favors HAE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.